103 related articles for article (PubMed ID: 30897525)
21. Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer.
Dasgupta P; Kulkarni P; Bhat NS; Majid S; Shiina M; Shahryari V; Yamamura S; Tanaka Y; Gupta RK; Dahiya R; Hashimoto Y
Toxicol Appl Pharmacol; 2020 Aug; 401():115102. PubMed ID: 32512071
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis.
Qu T; Li YP; Li XH; Chen Y
Mol Med Rep; 2016 Dec; 14(6):5041-5048. PubMed ID: 27779685
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of mRNA-m
Wu B; Jiang X; Huang Y; Ying X; Zhang H; Liu B; Li Z; Qi D; Ji W; Cai X
Biomarkers; 2021 Sep; 26(6):499-507. PubMed ID: 33830842
[No Abstract] [Full Text] [Related]
24. Biological and molecular modifications induced by cadmium and arsenic during breast and prostate cancer development.
Zimta AA; Schitcu V; Gurzau E; Stavaru C; Manda G; Szedlacsek S; Berindan-Neagoe I
Environ Res; 2019 Nov; 178():108700. PubMed ID: 31520827
[TBL] [Abstract][Full Text] [Related]
25. [Gene expression profiles in normal human prostate epithelial cells exposed to low-dose cadmium: A bioinformatics analysis].
Guo YS; Xu XF; Li N; Sun N; Duan LF
Zhonghua Nan Ke Xue; 2019 Feb; 25(2):103-109. PubMed ID: 32216194
[TBL] [Abstract][Full Text] [Related]
26. Integrated Bioinformatics Analysis of Potential Biomarkers for Prostate Cancer.
Tan J; Jin X; Wang K
Pathol Oncol Res; 2019 Apr; 25(2):455-460. PubMed ID: 29260398
[TBL] [Abstract][Full Text] [Related]
27. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
[TBL] [Abstract][Full Text] [Related]
28. Fibronectin 1 as a Key Gene in the Genesis and Progression of Cadmium-Related Bladder Cancer.
Zhang L; Wang Y; Song M; Chang A; Zhuo W; Zhu Y
Biol Trace Elem Res; 2023 Sep; 201(9):4349-4359. PubMed ID: 36471209
[TBL] [Abstract][Full Text] [Related]
29. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of potential target genes in papillary thyroid cancer.
Zhang K; Liu J; Li C; Peng X; Li H; Li Z
Eur J Pharmacol; 2019 Jan; 843():217-225. PubMed ID: 30472204
[TBL] [Abstract][Full Text] [Related]
31. Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
Huang H; Zhang Q; Ye C; Lv JM; Liu X; Chen L; Wu H; Yin L; Cui XG; Xu DF; Liu WH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2571-2579. PubMed ID: 28849390
[TBL] [Abstract][Full Text] [Related]
32. Toxicogenomics applied to in vitro Cell Transformation Assay reveals mechanisms of early response to cadmium.
Callegaro G; Forcella M; Melchioretto P; Frattini A; Gribaldo L; Fusi P; Fabbri M; Urani C
Toxicol In Vitro; 2018 Apr; 48():232-243. PubMed ID: 29408670
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis.
Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR
Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031
[TBL] [Abstract][Full Text] [Related]
34. Analyzing the LncRNA, miRNA, and mRNA Regulatory Network in Prostate Cancer with Bioinformatics Software.
He JH; Han ZP; Zou MX; Wang L; Lv YB; Zhou JB; Cao MR; Li YG
J Comput Biol; 2018 Feb; 25(2):146-157. PubMed ID: 28836827
[TBL] [Abstract][Full Text] [Related]
35. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
Yu J; Mai W; Cui Y; Kong L
J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatics analysis of key genes and potential mechanism in cadmium-induced breast cancer progression.
Wu F; Zhang Y; Chen X; Wang Y; Peng H; Zhang Z; Yang Y; Wang Q
Environ Sci Pollut Res Int; 2022 Feb; 29(8):11883-11892. PubMed ID: 34558042
[TBL] [Abstract][Full Text] [Related]
37. Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks.
Deng SP; Zhu L; Huang DS
BMC Genomics; 2015; 16 Suppl 3(Suppl 3):S4. PubMed ID: 25707808
[TBL] [Abstract][Full Text] [Related]
38. [High throughput screening and analysis of prostate cancer-related genes through mining databases].
Wu G; Peng L; Jin FS; Li QS
Ai Zheng; 2006 May; 25(5):645-50. PubMed ID: 16687091
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
40. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
